Literature DB >> 15066182

HIV-1 gp41 and gp160 are hyperthermostable proteins in a mesophilic environment. Characterization of gp41 mutants.

Tino Krell1, Frédéric Greco, Olivier Engel, Jean Dubayle, Joseline Dubayle, Audrey Kennel, Benoit Charloteaux, Robert Brasseur, Michel Chevalier, Regis Sodoyer, Raphaëlle El Habib.   

Abstract

HIV gp41(24-157) unfolds cooperatively over the pH range of 1.0-4.0 with T(m) values of > 100 degrees C. At pH 2.8, protein unfolding was 80% reversible and the DeltaH(vH)/DeltaH(cal) ratio of 3.7 is indicative of gp41 being trimeric. No evidence for a monomer-trimer equilibrium in the concentration range of 0.3-36 micro m was obtained by DSC and tryptophan fluorescence. Glycosylation of gp41 was found to have only a marginal impact on the thermal stability. Reduction of the disulfide bond or mutation of both cysteine residues had only a marginal impact on protein stability. There was no cooperative unfolding event in the DSC thermogram of gp160 in NaCl/P(i), pH 7.4, over a temperature range of 8-129 degrees C. When the pH was lowered to 5.5-3.4, a single unfolding event at around 120 degrees C was noted, and three unfolding events at 93.3, 106.4 and 111.8 degrees C were observed at pH 2.8. Differences between gp41 and gp160, and hyperthermostable proteins from thermophile organisms are discussed. A series of gp41 mutants containing single, double, triple or quadruple point mutations were analysed by DSC and CD. The impact of mutations on the protein structure, in the context of generating a gp41 based vaccine antigen that resembles a fusion intermediate state, is discussed. A gp41 mutant, in which three hydrophobic amino acids in the gp41 loop were replaced with charged residues, showed an increased solubility at neutral pH.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15066182     DOI: 10.1111/j.1432-1033.2004.04068.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  10 in total

1.  The membrane proximal external regions of gp41 from HIV-1 strains HXB2 and JRFL have different sensitivities to alanine mutation.

Authors:  Hyun Ah Yi; Barbara Diaz-Rohrer; Priyanka Saminathan; Amy Jacobs
Journal:  Biochemistry       Date:  2015-02-19       Impact factor: 3.162

2.  Significant differences in cell-cell fusion and viral entry between strains revealed by scanning mutagenesis of the C-heptad repeat of HIV gp41.

Authors:  Barbara Diaz-Aguilar; Karen Dewispelaere; Hyun Ah Yi; Amy Jacobs
Journal:  Biochemistry       Date:  2013-05-07       Impact factor: 3.162

3.  Molecular and Physicochemical Factors Governing Solubility of the HIV gp41 Ectodomain.

Authors:  Fadia Manssour-Triedo; Sara Crespillo; Bertrand Morel; Salvador Casares; Pedro L Mateo; Frank Notka; Marie G Roger; Nicolas Mouz; Raphaelle El-Habib; Francisco Conejero-Lara
Journal:  Biophys J       Date:  2016-08-23       Impact factor: 4.033

Review 4.  Targeting HIV-1 gp41-induced fusion and pathogenesis for anti-viral therapy.

Authors:  Himanshu Garg; Mathias Viard; Amy Jacobs; Robert Blumenthal
Journal:  Curr Top Med Chem       Date:  2011-12       Impact factor: 3.295

5.  Comparative analysis of membrane-associated fusion peptide secondary structure and lipid mixing function of HIV gp41 constructs that model the early pre-hairpin intermediate and final hairpin conformations.

Authors:  Kelly Sackett; Matthew J Nethercott; Raquel F Epand; Richard M Epand; Douglas R Kindra; Yechiel Shai; David P Weliky
Journal:  J Mol Biol       Date:  2010-01-18       Impact factor: 5.469

Review 6.  Inhibition of HIV Entry by Targeting the Envelope Transmembrane Subunit gp41.

Authors:  Hyun A Yi; Brian C Fochtman; Robert C Rizzo; Amy Jacobs
Journal:  Curr HIV Res       Date:  2016       Impact factor: 1.581

7.  Stability of a receptor-binding active human immunodeficiency virus type 1 recombinant gp140 trimer conferred by intermonomer disulfide bonding of the V3 loop: differential effects of protein disulfide isomerase on CD4 and coreceptor binding.

Authors:  J Billington; T P Hickling; G H Munro; C Halai; R Chung; G G Dodson; R S Daniels
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

8.  Sublingual Priming with a HIV gp41-Based Subunit Vaccine Elicits Mucosal Antibodies and Persistent B Memory Responses in Non-Human Primates.

Authors:  Selma Bekri; Pierre Bourdely; Carmelo Luci; Nathalie Dereuddre-Bosquet; Bin Su; Frédéric Martinon; Véronique M Braud; Irene Luque; Pedro L Mateo; Sara Crespillo; Francisco Conejero-Lara; Christiane Moog; Roger Le Grand; Fabienne Anjuère
Journal:  Front Immunol       Date:  2017-02-01       Impact factor: 7.561

9.  A High Frequency of HIV-Specific Circulating Follicular Helper T Cells Is Associated with Preserved Memory B Cell Responses in HIV Controllers.

Authors:  M Claireaux; M Galperin; D Benati; A Nouël; M Mukhopadhyay; J Klingler; P de Truchis; D Zucman; S Hendou; F Boufassa; C Moog; O Lambotte; L A Chakrabarti
Journal:  MBio       Date:  2018-05-08       Impact factor: 7.867

10.  Distinct antibody profiles in HLA-B∗57+, HLA-B∗57- HIV controllers and chronic progressors.

Authors:  Jéromine Klingler; Nicodème Paul; Géraldine Laumond; Sylvie Schmidt; Luzia M Mayr; Thomas Decoville; Olivier Lambotte; Brigitte Autran; Seiamak Bahram; Christiane Moog
Journal:  AIDS       Date:  2022-03-15       Impact factor: 4.177

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.